Dishman Carbogen Amcis shines on the BSE

21 May 2021 Evaluate

Dishman Carbogen Amcis is currently trading at Rs. 194.05, up by 8.20 points or 4.44% from its previous closing of Rs 184.80 on the BSE.

The scrip opened at Rs. 186.00 and has touched a high and low of Rs. 199.80 and Rs. 186.00 respectively. So far 333032 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 216.65 on 04-Aug-2020 and a 52 week low of Rs. 63.45 on 01-Jun-2020.

Last one week high and low of the scrip stood at Rs. 194.40 and Rs. 165.35 respectively. The current market cap of the company is Rs. 3005.53 crore.

The promoters holding in the company stood at 59.32%, while Institutions and Non-Institutions held 15.32% and 25.36% respectively.

Dishman Carbogen Amcis has welcomed the results of a new study that provides critical insights into the treatment of vitamin D deficiency in obesity and in fat malabsorption syndromes. The research was conducted by Boston University School of Medicine and supported in part by a grant from Dishman Carbogen Amcis’ wholly owned subsidiary CARBOGEN AMCIS B.V.

Dishman Carbogen Amcis provides innovative solutions for the development and supply of drug substances and drug products to the pharmaceutical and biopharmaceutical industries.

Dishman Carbogen Amc Share Price

223.15 -5.45 (-2.38%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×